Galmed Pharmaceuticals Ltd

NASDAQ:GLMD   3:46:53 PM EDT
0.38
+0.01 (+2.80%)
: $0.40 +0.02 (+5.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Galmed Pharmaceuticals Ltd Stock, NASDAQ:GLMD

16 Zeev Tiomkin Street, 16 Abba Hillel Road, Ramat Gan, Tel Aviv 5250608
Israel
Phone: +972.3.693.8448
Number of Employees: 8
http://galmedpharma.com

Description

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.